Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kyntra Bio (KYNB) Asset Writedowns and Impairment (2023)

Historic Asset Writedowns and Impairment for Kyntra Bio (KYNB) over the last 1 years, with Q1 2023 value amounting to $1.0 million.

  • Kyntra Bio's Asset Writedowns and Impairment changed N/A to $1.0 million in Q1 2023 from the same period last year, while for Dec 2023 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2023, which is N/A changed from last year.
  • As of Q1 2023, Kyntra Bio's Asset Writedowns and Impairment stood at $1.0 million.
  • In the past 5 years, Kyntra Bio's Asset Writedowns and Impairment ranged from a high of $1.0 million in Q1 2023 and a low of $1.0 million during Q1 2023